Translated title of the contribution: Adjuvant chemotherapy in breast cancer: Results and indications

K. W. Brunner, A. Goldhirsch, R. Joss, R. W. Sonntag, L. Tschopp

Research output: Contribution to journalArticlepeer-review


As the observation times of current studies using adjuvant chemotherapy in the treatment of operable stage II breast cancer lengthen, the probability of significantly reducing the high risk of developing metastases associated with this stage of the disease is also increasing and should be reflected in improved cure rates. The theoretical basis, prerequisites and presently available results for adjuvant chemotherapy of breast cancer are discussed. Adjuvant combination chemotherapy provides better results than monochemotherapy with Alkeran. While earlier results suggested that adjuvant chemotherapy is especially effective in premenopausal women, newer studies and analyses indicate that appropriate dosage and consistent administration of chemotherapy are of decisive importance. Exact determination and documentation of the tumor stage, and especially the regional lymph node status, is the most important factor in determining the indication for adjuvant chemotherapy. Adjuvant chemotherapy is still beset with many unsolved problems. These include the duration, necessary intensity based upon risk factors, and short- and long-term side effects.

Translated title of the contributionAdjuvant chemotherapy in breast cancer: Results and indications
Original languageGerman
Pages (from-to)838-845
Number of pages8
JournalSchweizerische Medizinische Wochenschrift
Issue number23
Publication statusPublished - 1981

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Adjuvant chemotherapy in breast cancer: Results and indications'. Together they form a unique fingerprint.

Cite this